Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Gail Jones.

Newcastle AuthorsTitleYearFull text
Dr Gail Jones
A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemia2022
Dr Wei-yu Lin
Dr Sarah Fordham
Dr Nicola Sunter
Dr Claire Elstob
Dr Yaobo Xu
et al.
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (Nature Communications, (2021), 12, 1, (6233), 10.1038/s41467-021-26551-x)2022
Dr Gail Jones
British Society for Haematology guidelines for the management of adult myelodysplastic syndromes2021
Dr Wei-Yu Lin
Dr Sarah Fordham
Dr Nicola Sunter
Dr Claire Elstob
Dr Yaobo Xu
et al.
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia2021
Dr Paul Milne
Dr Venetia Bigley
Dr Amy Publicover
Sarah Pagan
Dr Helen Marr
et al.
Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia2019
Dr Sarah Fordham
Dr Helen Blair
Dr Claire Elstob
Professor Ruth Plummer
Dr Yvette Drew
et al.
Inhibition of ATR acutely sensitises acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase2018
Dr Gail Jones
Measurable residual disease at induction redefines partial response in acute myeloid leukemia and stratifies outcomes in patients at standard risk without NPM1 mutations2018
Dr Gail Jones
A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML2017
Dr Gail Jones
Professor Graham Jackson
Evolving concepts in tumour lysis syndrome management - response to Ayed et al2016
Dr Tom Creasey
Dr Gail Jones
Professor Matthew Collin
Granulocyte infusion: benefit beyond neutrophils?2016
Dr Gail Jones
Professor Graham Jackson
Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology2015
Dr Nicholas Bown
Gavin Cuthbert
Dr Gail Jones
A United Kingdom Population-Based Study of Survival in Patients Aged 19 to 60 with Acute Myeloid Leukaemia in the Era of Molecular Genetics2014
Dr Jonathan Wallis
Dr Gail Jones
Alloantibody formation in the frequently transfused haemato-oncology patient - an audit of alloimmunisation rates and the cost effectiveness of a 'proactive versus reactive' transfusion regimen2014
Dr Gail Jones
Guidelines for the diagnosis and management of adult myelodysplastic syndromes2014
Dr Gail Jones
A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers2013